Search Results - "Mousa, SA"

Relative contribution of peripheral versus central opioid receptors to antinociception by Labuz, Dominika, Mousa, Shaaban A, Schäfer, Michael, Stein, Christoph, Machelska, Halina

“…Abstract Opioid effects are mediated by central and peripheral opioid receptors. Here we examine the relative contribution of each receptor population to…”
Get full text

p38 Mitogen-activated Protein Kinase Activation by Nerve Growth Factor in Primary Sensory Neurons Upregulates μ-Opioid Receptors to Enhance Opioid Responsiveness Toward Better Pain Control by YAMDEU, Reine-Solange, SHAQURA, Mohammed, MOUSA, Shaaban A, SCHAFER, Michael, DROESE, Jana

“…Sensory neuron opioid receptors are targets for spinal, epidural, and peripheral opioid application. Although local nerve growth factor (NGF) has been…”
Get full text

Pain control in inflammation governed by selectins by Machelska, Halina, Cabot, Peter J, Mousa, Shaaban A, Zhang, Qin, Stein, Christoph

“…Opioid-containing immune cells migrate preferentially to inflamed sites, where they release beta-endorphin which activates peripheral opioid receptors to…”
Get full text

Morphological correlates of immune-mediated peripheral opioid analgesia by Mousa, Shaaban A

“…The immune system is a source of opioid peptides and plays an important role in the control of inflammatory pain. Inflammation not only increases the opioid…”
Get more information

Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia by Likar, R., Mousa, S.A., Philippitsch, G., Steinkellner, H., Koppert, W., Stein, C., Schäfer, M.

“…Both locally expressed β-endorphin (END) and low doses of morphine relieve pain within inflamed knee joints. Here we examined whether enhanced inflammation and…”
Get full text

Pharmacodynamic Properties of the Low Molecular Weight Heparin, Tinzaparin: Effect of Molecular Weight Distribution on Plasma Tissue Factor Pathway Inhibitor in Healthy Human Subjects by Mousa, Shaker A., Bozarth, Jeffrey, Barrett, Jeffrey S.

“…Low molecular weight heparins (LMWHs) stimulate the release of endothelial tissue factor pathway inhibitor (TFPI). An inhibitor of tissue factor—induced…”
Get full text

Angiogenesis inhibitors: current & future directions by Mousa, Shaker A, Mousa, Ahmed S

“…The field of angiogenesis modulation is at a major crossroad. A tremendous advancement in basic science in this field is providing an excellent support for the…”
Get more information

Corticotropin-releasing factor in antinociception and inflammation by Schäfer, Michael, Mousa, Shaaban A, Stein, Christoph

“…Corticotropin-releasing factor (CRF) plays a major role at the level of the hypothalamus and pituitary to control the body's response mechanisms to stressful…”
Get full text

Recent advances in cell adhesion molecules and extracellular matrix proteins: potential clinical implications by Mousa, Shaker A., Cheresh, David A.

“…The roles of cell adhesion molecules (CAMs) and extracellular matrix proteins (ECMs) in various pathological processes leading to both acute and chronic…”
Get full text

Immunocytochemical study on the localization and distribution of the somatolactin cells in the pituitary gland and the brain of Oreochromis niloticus (Teleostei, cichlidae) by Mousa, M A, Mousa, S A

“…Using specific antibody for chum salmon somatolactin (SL), immunocytochemical studies were employed to determine the distribution of this hormone in the…”
Get full text

Emerging therapies for Parkinson's disease: From bench to bedside by TARAZI, F. I, SAHLI, Z. T, WOLNY, M, MOUSA, S. A

“…The prevalence of Parkinson's disease (PD) increases with age and is projected to increase in parallel to the rising average age of the population. The disease…”
Get full text

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer by FARGE, D., DEBOURDEAU, P., BECKERS, M., BAGLIN, C., BAUERSACHS, R. M., BRENNER, B., BRILHANTE, D., FALANGA, A., GEROTZAFIAS, G. T., HAIM, N., KAKKAR, A. K., KHORANA, A. A., LECUMBERRI, R., MANDALA, M., MARTY, M., MONREAL, M., MOUSA, S. A., NOBLE, S., PABINGER, I., PRANDONI, P., PRINS, M. H., QARI, M. H., STREIFF, M. B., SYRIGOS, K., BOUNAMEAUX, H., BÜLLER, H. R.

“…Background: Guidelines addressing the management of venous thromboembolism (VTE) in cancer patients are heterogeneous and their implementation has been…”
Get full text

Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer by Rajabi, Mehdi, Yalcin, Murat, Mousa, Shaker A.

“…The phenolic hydroxyl group (–OH) of tetrac is selected as its modification site and as a target site for converting tetrac to an integrin antagonist without…”
Get full text

Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation by Mousa, Deena S, El-Far, Ali H, Saddiq, Amna A, Sudha, Thangirala, Mousa, Shaker A

“…This study was designed to determine the potential effect of nanoencapsulated bioactive compounds from different natural sources on human pancreatic cancer…”
Get full text

Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention by Shirode, Amit B, Bharali, Dhruba J, Nallanthighal, Sameera, Coon, Justin K, Mousa, Shaker A, Reliene, Ramune

“…Pomegranate polyphenols are potent antioxidants and chemopreventive agents but have low bioavailability and a short half-life. For example, punicalagin (PU),…”
Get full text

Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications by DAVIS, Paul J, DAVIS, Faith B, MOUSA, Shaker A, LUIDENS, Mary K, LIN, Hung-Yun

“…Plasma membrane integrin αvβ3 is a cell surface receptor for thyroid hormone at which nongenomic actions are initiated. L-thyroxine (T₄) and…”
Get full text

High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study by Ardawi, Mohammed-Salleh M, Rouzi, Abdulrahim A, Al-Sibiani, Sharifa A, Al-Senani, Nawal S, Qari, Mohammed H, Mousa, Shaker A

“…Sclerostin regulates bone formation by inhibiting Wnt pathway signaling. Low circulating sclerostin levels cause high bone mass. We hypothesized that…”
Get full text

Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release by Shahein, Samar A, Aboul-Enein, Ahmed M, Higazy, Iman M, Abou-Elella, Faten, Lojkowski, Witold, Ahmed, Esam R, Mousa, Shaker A, AbouAitah, Khaled

“…Glioma is one of the most aggressive primary brain tumors and is incurable. Surgical resection, radiation, and chemotherapies have been the standard treatments…”
Get full text

Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease by Qari, M H, Dier, U, Mousa, S A

“…Acute painful crisis is a common sequela that can cause significant morbidity and negatively impact the quality of life of patients with sickle cell disease…”
Get more information

IR-enhanced photothermal therapeutic effect of graphene magnetite nanocomposite on human liver cancer HepG2 cell model by Salaheldin, Taher A, Loutfy, Samah A, Ramadan, Marwa A, Youssef, Tareq, Mousa, Shaker A

“…Graphene magnetite nanocomposites (G/Fe O ) exhibit light photothermal conversion upon enhancement by 808 nm IR laser excitation. We evaluated the cytotoxic…”
Get full text